From the scientific controversy around DMAA to a major resveratrol research fraud scandal, plus all the latest developments in gut health, omega-3 and vitamin science; 2012 has been an eventful year for research in the health and nutrition arena.
Neptune Technologies and Bioressources has been hit with a shareholder rights lawsuit over the Nov. 8 explosion and fire that destroyed the company’s production facility and a resulting steep decline in the company’s share price.
Business consolidation, battling stalling economies and the belated activation of the dreaded (by most) EU health claims register – these are just a few issues that have defined the 2012 EU nutra space.
Virun CEO Philip Bromley tells Ben Bouckley about the firm’s evolution from drug delivery technology into the beverage sphere, and explains that DHA and EPA Omega-3 oils dominate functional demands from clients.
German fragrance and flavours house Symrise has just last night inked a deal with Swedish probiotics firm Probi to develop a stand-alone R&D project with oral probiotic supplements the most likely product out of the pipeline in 2014-2015.